138 related articles for article (PubMed ID: 17129358)
1. Up-regulation of a BCL9-related beta-catenin-binding protein, B9L, in different stages of sporadic colorectal adenoma.
Sakamoto I; Ohwada S; Toya H; Togo N; Kashiwabara K; Oyama T; Nakajima T; Ito H; Adachi S; Jigami T; Akiyama T
Cancer Sci; 2007 Jan; 98(1):83-7. PubMed ID: 17129358
[TBL] [Abstract][Full Text] [Related]
2. Role of a BCL9-related beta-catenin-binding protein, B9L, in tumorigenesis induced by aberrant activation of Wnt signaling.
Adachi S; Jigami T; Yasui T; Nakano T; Ohwada S; Omori Y; Sugano S; Ohkawara B; Shibuya H; Nakamura T; Akiyama T
Cancer Res; 2004 Dec; 64(23):8496-501. PubMed ID: 15574752
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological significance of expression of p-c-Jun, TCF4 and beta-Catenin in colorectal tumors.
Takeda K; Kinoshita I; Shimizu Y; Ohba Y; Itoh T; Matsuno Y; Shichinohe T; Dosaka-Akita H
BMC Cancer; 2008 Nov; 8():328. PubMed ID: 18992165
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical expression of the beta-catenin-interacting protein B9L is associated with histological high nuclear grade and immunohistochemical ErbB2/HER-2 expression in breast cancers.
Toya H; Oyama T; Ohwada S; Togo N; Sakamoto I; Horiguchi J; Koibuchi Y; Adachi S; Jigami T; Nakajima T; Akiyama T
Cancer Sci; 2007 Apr; 98(4):484-90. PubMed ID: 17309600
[TBL] [Abstract][Full Text] [Related]
5. Flat adenoma-carcinoma sequence with high-malignancy potential as demonstrated by CD10 and beta-catenin expression: a different pathway from the polypoid adenoma-carcinoma sequence.
Koga Y; Yao T; Hirahashi M; Kumashiro Y; Ohji Y; Yamada T; Tanaka M; Tsuneyoshi M
Histopathology; 2008 Apr; 52(5):569-77. PubMed ID: 18370954
[TBL] [Abstract][Full Text] [Related]
6. Expression of the ets-1 proto-oncogene in human colorectal carcinoma.
Nakayama T; Ito M; Ohtsuru A; Naito S; Sekine I
Mod Pathol; 2001 May; 14(5):415-22. PubMed ID: 11353051
[TBL] [Abstract][Full Text] [Related]
7. BCL9-2 promotes early stages of intestinal tumor progression.
Brembeck FH; Wiese M; Zatula N; Grigoryan T; Dai Y; Fritzmann J; Birchmeier W
Gastroenterology; 2011 Oct; 141(4):1359-70, 1370.e1-3. PubMed ID: 21703997
[TBL] [Abstract][Full Text] [Related]
8. [Expression and significance of APC, beta-catenin, C-myc, and Cyclin D1 proteins in colorectal carcinoma].
Dai WB; Ren ZP; Chen WL; DU J; Shi Z; Tang DY
Ai Zheng; 2007 Sep; 26(9):963-6. PubMed ID: 17927853
[TBL] [Abstract][Full Text] [Related]
9. The nuclear to cytoplasmic shift of ING5 protein during colorectal carcinogenesis with their distinct links to pathologic behaviors of carcinomas.
Zheng HC; Xia P; Xu XY; Takahashi H; Takano Y
Hum Pathol; 2011 Mar; 42(3):424-33. PubMed ID: 21193223
[TBL] [Abstract][Full Text] [Related]
10. A colorectal cancer expression profile that includes transforming growth factor beta inhibitor BAMBI predicts metastatic potential.
Fritzmann J; Morkel M; Besser D; Budczies J; Kosel F; Brembeck FH; Stein U; Fichtner I; Schlag PM; Birchmeier W
Gastroenterology; 2009 Jul; 137(1):165-75. PubMed ID: 19328798
[TBL] [Abstract][Full Text] [Related]
11. Aberrant expression of human ortholog of mammalian enabled (hMena) in human colorectal carcinomas: implications for its role in tumor progression.
Toyoda A; Kawana H; Azuhata K; Yu J; Omata A; Kishi H; Higashi M; Harigaya K
Int J Oncol; 2009 Jan; 34(1):53-60. PubMed ID: 19082477
[TBL] [Abstract][Full Text] [Related]
12. Telomerase activity and hTERT mRNA in development and progression of adenoma to colorectal cancer.
Kanamaru T; Tanaka K; Kotani J; Ueno K; Yamamoto M; Idei Y; Hisatomi H; Takeyama Y
Int J Mol Med; 2002 Aug; 10(2):205-10. PubMed ID: 12119560
[TBL] [Abstract][Full Text] [Related]
13. Inverse correlation of the up-regulation of FZD10 expression and the activation of beta-catenin in synchronous colorectal tumors.
Nagayama S; Yamada E; Kohno Y; Aoyama T; Fukukawa C; Kubo H; Watanabe G; Katagiri T; Nakamura Y; Sakai Y; Toguchida J
Cancer Sci; 2009 Mar; 100(3):405-12. PubMed ID: 19134005
[TBL] [Abstract][Full Text] [Related]
14. TGF-beta 1 in colonic neoplasia. A genetic molecular and immunohistochemical study.
Cardillo MR; Yap EP
Arch Anat Cytol Pathol; 1996; 44(5-6):241-9. PubMed ID: 9339011
[TBL] [Abstract][Full Text] [Related]
15. A novel gene containing PDZ and LIM domains, PCD1, is overexpressed in human colorectal cancer.
Furuya M; Tsuji N; Endoh T; Moriai R; Kobayashi D; Yagihashi A; Watanabe N
Anticancer Res; 2002; 22(6C):4183-6. PubMed ID: 12553053
[TBL] [Abstract][Full Text] [Related]
16. Growth hormone receptor expression is up-regulated during tumorigenesis of human colorectal cancer.
Wu X; Liu F; Yao X; Li W; Chen C
J Surg Res; 2007 Dec; 143(2):294-9. PubMed ID: 17764692
[TBL] [Abstract][Full Text] [Related]
17. [Association of galectin-3 expression with biological behaviors of human colorectal carcinoma].
Zhang N; Ding YQ; Liang L
Nan Fang Yi Ke Da Xue Xue Bao; 2006 Dec; 26(12):1685-9. PubMed ID: 17259097
[TBL] [Abstract][Full Text] [Related]
18. The Immunohistochemical expression of endothelial cell differentiation gene-2 receptor in human colorectal adenomas.
Komuro Y; Watanabe T; Kitayama J; Yamaguchi H; Tsuno N; Nagawa H
Hepatogastroenterology; 2003; 50(54):1770-3. PubMed ID: 14696401
[TBL] [Abstract][Full Text] [Related]
19. Role and prognostic significance of CD44s expression in colorectal cancer.
Visca P; Del Nonno F; Botti C; Marandino F; Sebastiani V; Di Tondo U; Donnorso RP; Trombetta G; Filippi S; Alo PL
Anticancer Res; 2002; 22(5):2671-5. PubMed ID: 12529980
[TBL] [Abstract][Full Text] [Related]
20. Analysis of SOX9 expression in colorectal cancer.
Lü B; Fang Y; Xu J; Wang L; Xu F; Xu E; Huang Q; Lai M
Am J Clin Pathol; 2008 Dec; 130(6):897-904. PubMed ID: 19019766
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]